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During mitosis, the spindle assembly checkpoint
(SAC) monitors the attachment of kinetochores
(KTs) to the plus ends of spindle microtubules
(MTs) and prevents anaphase onset until chromo-
somes are aligned and KTs are under proper tension.
Here, we identify a SAC component, BuGZ/ZNF207,
from an RNAi viability screen in human glioblastoma
multiforme (GBM) brain tumor stem cells. BuGZ
binds to and stabilizes Bub3 during interphase and
mitosis through a highly conserved GLE2p-binding
sequence (GLEBS) domain. Inhibition of BuGZ re-
sults in loss of both Bub3 and its binding partner
Bub1 from KTs, reduction of Bub1-dependent phos-
phorylation of centromeric histone H2A, attenuation
of KT-based Aurora B kinase activity, and lethal
chromosome congression defects in cancer cells.
Phylogenetic analysis indicates that BuGZ ortho-
logs are highly conserved among eukaryotes, but
are conspicuously absent from budding and fission
yeasts. These findings suggest that BuGZ has
evolved to facilitate Bub3 activity and chromosome
congression in higher eukaryotes.
INTRODUCTION
During mitosis, the spindle assembly checkpoint (SAC) monitors
the attachment of kinetochores (KTs) to the plus ends of spindle
microtubules (MTs) and prevents anaphase onset until chromo-
somes are aligned and KTs are under proper tension (Lara-
Gonzalez et al., 2012; Santaguida and Musacchio, 2009). The
SAC machinery contains multiple KT proteins (i.e., Bub1,
BubR1, Bub3, Mad1, Mad2, and Mps1) that monitor MT attach-
ment and regulate anaphase progression (Lara-Gonzalez et al.,
2012; Santaguida and Musacchio, 2009). The SAC proteins
Mad2, BubR1, and Bub3 comprise the soluble Mitotic Check-282 Developmental Cell 28, 282–294, February 10, 2014 ª2014 Elsevpoint Complex (MCC) and prevent activation of the ubiquitin
ligase anaphase-promoting complex/cyclosome (APC/C) by tar-
geting APC/C’s cofactor, Cdc20 (Musacchio and Salmon, 2007).
Following proper chromosome alignment and tension at the KT,
Cdc20 inhibition is released to activate the APC/C, which begins
the cascade of events that lead to anaphase (Musacchio and
Salmon, 2007).
In addition, Bub1, BubR1, and Bub3 have been implicated in
promoting chromosome alignment through regulation of Aurora
B kinase (ABK) activity at KTs during chromosome congression
(Lampson and Kapoor, 2005; Logarinho et al., 2008; Meraldi
andSorger, 2005). Inprometaphase,Bub1kinasephosphorylates
threonine 120 of centromere-bound Histone 2A (pH2A-T120),
which facilitates recruitment of ABK to the KT (Ricke et al.,
2012; Taylor et al., 1998; Yamagishi et al., 2010). ABK, in turn,
phosphorylates KT-MT attachment proteins, which reduces their
bindingaffinity forMTsandprevents thepremature stabilizationof
KT-MTattachments (Cheesemanet al., 2006;DeLucaet al., 2006,
2011; Welburn et al., 2010). In contrast to Bub1, BubR1 activity
opposes ABK-dependent phosphorylation of KT-binding factors
by recruitingPP2Aphosphatase to theKT (Kruse et al., 2013;Suij-
kerbuijk et al., 2012). The interplay between these opposing activ-
ities regulates the formation of stable end-onKT-MT attachments
(Kruse et al., 2013; LampsonandKapoor, 2005; Suijkerbuijk et al.,
2012). Bub3 is required to recruit both Bub1 and BubR1 to KTs
(Harris et al., 2005; Wang et al., 2001), and Bub3 inhibition results
in chromosome congression defects consistentwith loss of Bub1
function at KTs (Logarinho et al., 2008).
Bub1 and BubR1 both interact with Bub3 through highly
conserved GLEBS domains (Bailer et al., 1998; Taylor et al.,
1998; Wang et al., 2001). These are short, disordered regions
of about 40 amino acids that form a series of salt bridges
between the WD40 domains of Bub3 and two glutamate resi-
dues in the GLEBS domain (Larsen et al., 2007). As a result of
Bub3 binding, the GLEBS domain undergoes a conformational
shift from a disordered to a well-ordered structure with fixed
interaction points on the top face of Bub3’s WD40 propeller
(Larsen et al., 2007). This interaction is critical for Bub3-depen-
dent recruitment of Bub1 and BubR1 to KTs (Harris et al.,
2005; Taylor et al., 1998; Wang et al., 2001). For example, aier Inc.
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sufficient to prevent Bub3 interaction and BubR1’s KT localiza-
tion (Harris et al., 2005).
We previously found that human glioblastoma multiforme
(GBM) brain tumors, the most common and lethal form of brain
cancer, differentially require BubR1’s GLEBS domain to sup-
press the lethal consequences of altered KT function by promot-
ing attachment of MTs to KTs (Ding et al., 2013). Removal of
BubR1 from KTs of GBM stem cells (GSCs) or transformed fibro-
blasts results in lethality due to a lack of KT-MT attachments,
whereas nontransformed cells are unaffected (Ding et al.,
2013; Malureanu et al., 2009). Thus, GBM isolates appear to
bemore sensitive to perturbation of certain activities of SAC pro-
teins than nontransformed cells. This added sensitivity in GSCs
led us to isolate a facilitator of Bub3 function, ZNF207, an
uncharacterized C2–H2 zinc-finger domain gene (Hubert et al.,
2013; Pahl et al., 1998). Because we implicate ZNF207 below
as a key effector of Bub3 function, we rename the gene BuGZ
(Bub3 interacting GLEBS and Zinc finger domain containing
protein). Here, we report that the human BuGZ/ZNF207 gene
encodes a GLEBS-domain-containing and KT-binding protein
that is required for Bub3 stability, Bub1 KT function, and chromo-
some alignment.
RESULTS
BuGZ was isolated from an RNAi screen targeting putative
human transcription factors to identify key regulators of the
expansion and survival of GSCs. As in our previous studies
(Ding et al., 2013; Hubert et al., 2013), we compared the GSC
screen results with those obtained from nontransformed human
neural stem cells (NSCs), a candidate cell of origin for GBM, to
identify GBM-specific lethality hits (Figure 1A). We found BuGZ
short hairpin RNAs (shRNAs) in this category. Thus, we set out
to validate BuGZ as a candidate cancer lethal gene and then
attempted to ascertain its cellular function.
Figures 1A–1D show that, consistent with the screen data,
BuGZ knockdown results in differential growth inhibition of
GSCs when compared with proliferating human NSCs. Multiple
shRNAs provided robust GSC-specific growth inhibition and
penetrant knockdown in both GSCs and NSCs (see also Fig-
ure S1A available online). Knockdown of KIF11/Eg5 was used
as a positive proliferation control. Its inhibition blocks the growth
of cultured cells regardless of transformation status (Figures 1B
and 1F; Ding et al., 2013; Hubert et al., 2013).
BuGZ knockdown also inhibited the growth of SSEA1+ GSC
subpopulations, which are enriched for tumor-initiating cell
activity (Son et al., 2009; Figure 1E), and inhibited tumor sphere
formation, a surrogate assay for stem cell self-renewal (Galli
et al., 2004; Singh et al., 2004; Figure S1B). However, BuGZ
knockdown did not alter expression of SSEA1 or other progenitor
markers, including SOX2 andNESTIN, or neural lineagemarkers,
including GFAP and TUJ1 (data not shown). Moreover, BuGZ-
knockdown-insensitive NSCs could be made sensitive by
genetic transformation with hTERT, dominant-negative p53DD,
CyclinD1, CDK4R24C, H-RasV12, and MYC (Hubert et al., 2013;
Kendall et al., 2005; Figure 1F). Other GSC patient isolates also
showed sensitivity to BuGZ knockdown, demonstrating that the
effect is not patient specific (Figure 1F). Finally, we performedDevelopman in vivo competition experiment to directly test the effects
of BuGZ suppression in an orthotropic xenograft model of
GBM by mixing GSCs containing GFP-expressing shBuGZ or
shControl with non-shRNA control GSCs at an approximate 9:1
ratio, respectively (Hubert et al., 2013). We found that 17 days
postinjection, the non-shRNA control GSCs drastically outcom-
peted the shBuGZ GSCs, and the shControl GSCs comprised
the bulk tumor mass (Figures 1G and S1C). Thus, BuGZ expres-
sion is required for GBM tumor formation in vivo. Taken together,
these results suggest that GSCs have a differential requirement
for BuGZ, which is likely driven by oncogenic activity.
To gain insight into the molecular function of BuGZ, we next
performed affinity purification mass spectrometry to identify
candidate protein-binding partners (see Supplemental Experi-
mental Procedures for details). This analysis revealed Bub3 as
the top-scoring hit (Figure 2A; Table S1). We confirmed this inter-
action in reciprocal coimmunoprecipitation experiments. BuGZ
was able to pull down Bub3, and vice versa in GSCs (Figure 2B)
and 293T cells (Figure S2), demonstrating that the proteins
interact in cells.
Because SAC signaling is an essential and highly conserved
process, we performed phylogenetic analysis to identify BuGZ
orthologs and examine available data regarding their function in
model genetic systems. BuGZ shows strong conservation
among eukaryotes, with the exception of budding and fission
yeasts, where no orthologs could be identified (Figure 2C; Powell
et al., 2012). This is in contrast to Bub3, which is highly conserved
in all eukaryotes, including budding and fission yeasts, where it
was first identified (Hoyt et al., 1991). Additionally, examination
of protein-protein interaction databases available for humans,
worms, flies, and plants revealed additional evidence for BuGZ
ortholog interaction with Bub3 from genome-scale yeast two-
hybrid screens or mass-spectrometry analysis (Table S2). How-
ever, other candidate proteins identified in our mass-spectrom-
etry analysis were not found. This suggests that BuGZ-Bub3
interactions are highly conserved among higher eukaryotes.
We next examined whether BuGZ interacts with Bub3 through
aGLEBSdomain similarly to Bub1 andBubR1.We observed that
BuGZ orthologs also harbor a single conserved GLEBS domain
motif (AA 344–376 for human), which contains the characteristic
two glutamate residues found in all GLEBS domains (AA 358 and
359 for human BuGZ; Figure 2D). Furthermore, mutational anal-
ysis of human BuGZ followed by immunoprecipitations revealed
that BuGZ’s GLEBS domain is required for interaction with Bub3,
whereas its zinc finger domains are dispensable (Figures 2E
and 2F). Thus, similarly to Bub1 and BubR1, BuGZ interacts
with Bub3 through a GLEBS domain.
To further explore the role of BuGZ-Bub3 binding, we evalu-
ated the protein levels of each binding partner after RNAi deple-
tion.We found that depletion of BuGZ led to an2-fold depletion
of Bub3 protein in GSCs, NSCs, and HeLa cells, whereas other
SAC and KT proteins (including Bub1, BubR1, Mad2L1, Hec1,
and Cdc20) were unaffected (Figures 3A, 3B, and S3A–S3C).
However, mRNA levels of BUB3 remain unchanged with BuGZ
knockdown (Figure 3C), suggesting the effects are not due to
transcriptional regulation or to off-target RNAi. In addition,
Bub3 loss due to BuGZ depletion can be rescued by overex-
pressing aBuGZ allele that is resistant to the shBuGZ (Figure 3D).
Moreover, mutational analysis revealed that the glutamic acidental Cell 28, 282–294, February 10, 2014 ª2014 Elsevier Inc. 283
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Figure 1. BuGZ Is a Candidate GBM-Lethal Gene
(A) An RNAi screen of putative transcription factors revealed that ZNF207/BuGZ is differentially required for GSC expansion as compared with NSCs.
(B) BuGZ knockdown causes loss of viability in GSCs, but not NSCs. Cells were infected with lentiviruses expressing BuGZ, KIF11, or control shRNAs, outgrown
for 7 days, and assayed for growth. Knockdown of KIF11 was used as a positive control for both RNAi knockdown and cell proliferation. All viral clones were
normalized to their respective shControl. **Student’s t test, p < 0.01, +SD.
(legend continued on next page)
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BuGZ Is Required for Bub3-Bub1 Functionresidues E358 and E359 of BuGZ’sGLEBS domain are critical for
Bub3 stability (Figure 3D). These two glutamic acid residues are
invariant among consensus residues for Bub1, BubR1, and
Nup98 GLEBS domains (Figure 2D) and are essential for their
binding to Bub3 or Rae1 (Bailer et al., 1998; Larsen et al.,
2007; Pritchard et al., 1999; Ren et al., 2010; Taylor et al.,
1998; Wang et al., 2001). These results suggest that the BuGZ-
Bub3 GLEBS-mediated interaction decreases protein turnover
of Bub3.
We next addressed whether BuGZ and Bub3 have overlap-
ping localization patterns in cells. Similar to reports for Bub3
(Taylor et al., 1998), we found that a BuGZ-GFP fusion localized
primarily to the nucleus in interphase, concentrated at KTs prior
to nuclear envelope breakdown and during early prometaphase,
and disappeared from KTs upon MT binding (Figure 3E). Immu-
nostaining of BuGZ revealed a similar localization pattern (Fig-
ure S4A). We next determined colocalization patterns of BuGZ
and Bub3 in HeLa cells. Just like BuGZ, Bub3 maximally local-
ized to KTs prior to nuclear envelope breakdown and remained
bound throughout prometaphase as previously described
(Howell et al., 2004; Figure 4A). However, unlike BuGZ, Bub3
persisted in low levels at metaphase KTs.
In contrast to BuGZ and Bub3 KT localization, Bub1 and
BubR1, which also associate with Bub3 via GLEBS domains,
concentrated at KTs after nuclear envelope breakdown (Fig-
ure S4B), consistent with previously published results (Jablonski
et al., 1998; Taylor and McKeon, 1997). Similar to what was
observed for these proteins, BuGZ’s GLEBS domain was
required for KT localization (Figure 4B), whereas its zinc finger
motifs were dispensable (Figure 4B). In addition, depletion of
Bub3 using RNAi prevented BuGZ localization to the KT (Fig-
ure 4C). Previous reports demonstrated that Bub3, Bub1, and
BubR1 all require KNL-1 in order to bind KTs (Kiyomitsu et al.,
2007; London et al., 2012; Primorac and Musacchio, 2013;
Yamagishi et al., 2012). We found that KNL-1 depletion also
resulted in a loss of BuGZ from KTs (Figure 4D). Moreover,
when cells were treated with nocodazole, causing spindle MTs
to depolymerize, unattached KTs reaccumulated BuGZ (Fig-
ure 4E). Conversely, treating cells with taxol, which stabilizes
KT-MT attachments, did not recruit BuGZ to MT-attached KTs
(Figure 4E). This behavior is similar to those previously observed
for Bub3 and other SAC proteins (Hoffman et al., 2001).
Together, these results indicate that BuGZ localizes to KTs by
binding to Bub3 through its GLEBS domain, and BuGZ’s KT
localization is regulated by attachment of MTs.
Previous studies reported that Bub3 and its binding partners
Bub1 and BubR1 exhibit interdependencies for KT localization(C and D)Western blot analysis and quantitative RT-PCR (qRT-PCR) for BuGZ pro
and NSC-CB660 following shRNA knockdown. **Student’s t test, p < 0.01, +SD.
(E) BuGZ knockdown compromises the growth of SSEA1+ GSC subpopula
shBuGZ-GFP+ or shControl-GFP+, mixed with untreated cells, and followed for
(F) BuGZ knockdown compromises the growth of transformed NSCs and mu
p < 0.01, +SD.
(G) Suppression of BuGZ expression compromises GBM tumor formation in vivo.
of GSC-0827 cells expressing GFP-shControl or GFP-shBuGZmixed with non-sh
marking shRNA-containing cells. Left: fluorescent signal from Tumor Paint (chloro
in the top row did not receive GSC-0827 cells or Tumor Paint, whereas the second
Paint. Quantification of GFP fluorescence is shown in Figure S1C. **Student’s t t
See also Figure S1.
Developm(Lara-Gonzalez et al., 2012; Santaguida and Musacchio, 2009).
We therefore analyzed KT localization of Bub3, Bub1, and
BubR1 in BuGZ-depleted HeLa cells. After BuGZ depletion,
Bub3 levels were reduced at KTs, which is not unexpected due
to the decrease in total protein (Figure 4F). Bub1 KT localization
was also significantly decreased (Figure 5A), which is likely
due to loss of its obligate KT recruitment factor Bub3 (Taylor
et al., 1998; Taylor and McKeon, 1997; Vanoosthuyse et al.,
2004). Intriguingly, BubR1 KT association was not affected after
BuGZ depletion (Figure 5A), though previous studies have
demonstrated that BubR1 KT recruitment relies on Bub3 (Loga-
rinho et al., 2008; Meraldi et al., 2004). It is possible that BubR1
outcompetes Bub1 to limit the Bub3-binding sites that remain
after BuGZ depletion, or alternatively, that BuGZ plays a more
direct role in Bub1 KT recruitment.
In addition to their well-known roles in SAC signaling, Bub1,
BubR1, and Bub3 have also been implicated in facilitating
chromosome alignment during mitosis (Lampson and Kapoor,
2005; Logarinho et al., 2008; Meraldi and Sorger, 2005). We
therefore examined chromosome alignment in BuGZ-depleted
HeLa cells treated with the proteasome inhibitor MG132 (to pre-
vent precocious anaphase entry), and found that this process
was significantly compromised (Figure 5B). In control popula-
tions, >95% of cells were able to fully align chromosomes,
whereas proper chromosome alignment was observed in
<55% of BuGZ-depleted cells (Figure 5B). We also detected
similar chromosome alignment defects in GSC-0131 and trans-
formed NSC-CB660 cells upon BuGZ depletion and MG132
treatment (Figure 5C). However, nontransformed NSC-CB660
cells were able to fully align chromosomes following BuGZ
loss (Figure 5C). In addition, codepleting both BuGZ and
Bub3 in GSC-0131 resulted in partial to severe chromosome
alignment defects similar to what was found with BuGZ and
Bub3 depletion alone (Figure 5D). The chromosome alignment
defects in GSC-131 following depletion of endogenous BuGZ
could be rescued by ectopic expression of the BuGZ ORF (Fig-
ure 5E), which further demonstrates that the chromosome align-
ment defects are due to BuGZ depletion and not to off-target
RNAi. However, BuGZ GLEBS domain mutations (E358K and
E359K) failed to rescue the chromosome alignment defects
(Figure 5E). The alignment defects were also observed in live
BuGZ-depleted cells, which exhibited significantly extended
mitotic transit times (120 min compared with 60 min in control
cells; Figures 5F and S5). Together, these results suggest that
oncogenic stress alters KT function, which leads to a differential
requirement for BuGZ’s GLEBS domain in cancer cells for chro-
mosome congression.tein andmRNA expression, respectively, of whole-cell extracts fromGSC-0131
tions. Flow-cytometry analysis of SSEA1+ GSC-0131 cells infected with
21 days in vitro under self-renewing conditions.
ltiple GSC isolates, but not NSCs (assay same as in B). **Student’s t test,
Images of in vivo competition mouse brains 17 days after orthotopic xenograft
RNA GSC-0827 cells. Right: light images of brains. Middle: GFP+ fluorescence
toxin:indocyanine green) to identify the total tumor mass. The first mouse brain
mouse brain in the top row did not receive GSC-0827 cells, but received Tumor
est, p < 0.01.
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Figure 2. BuGZ Binds to Bub3 through a Highly Conserved GLEBS Domain
(A) Results of affinity purificationmass spectrometry of 293T cell extracts transfectedwith GFP-tagged ZNF207 open reading frame (ORF). Bub3was identified as
the top candidate protein to interact with BuGZ. GFP control ORF was used to identify nonspecific protein interactions. Total results are presented in Table S1.
(B) BuGZ binds to Bub3 and vice versa. Western blot analysis with anti-turboGFP (BuGZ) and anti-Bub3 of immunoprecipitates with the turboGFP antibody
(BuGZ) or V5 antibody (Bub3) from GSC-0131 cells infected with V5-Bub3 and turboGFP-BuGZ constructs. FT, flowthrough; IP, immunoprecipitation; W1,
wash 1.
(C) Evolutionary distance between orthologs of ZNF207/BuGZ sampled from major phyla. Percent protein identity to human BuGZ from pairwise protein
alignments is indicated in parentheses (NCBI, HomoloGene database). Red dot indicates evidence for BuGZ-Bub3 interactions from protein-protein interaction
databases (Table S2).
(D) BuGZ orthologs contain a highly conserved GLEBS domain. GLEBS domains from hBub1 (AA240–280), hBubR1 (AA400–440), and hNup98 (157–213) (Larsen
et al., 2007; Wang et al., 2001) were used to create pairwise alignments of the indicated BuGZ orthologs using CLUSTALW.
(E) Human BuGZ alleles generated and used in these studies. FL, full-length BuGZORF; DZF1, deletion of the first zinc finger motif; DZF2, deletion of the second
zinc finger motif; DZF1, DZF2, deletion of the two zinc finger motifs; DGLEBS, deletion of a portion of the GLEBS motif.
(F) BuGZ binds to Bub3 through its GLEBS domain. Western blot analysis with anti-turboGFP and anti-Bub3 of immunoprecipitates with the turboGFP antibody
(BuGZ) from 293T cells transfected with the mutant alleles in (E) or the control (V5-Bub3).
See also Figure S2 and Tables S1 and S2.
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Figure 3. BuGZ Stabilizes Bub3 Expression and Localizes to the KT
(A) BuGZ stabilizes Bub3 expression. Western blot analysis of GSC-0131 whole-cell extracts infected with shControl or shBuGZ virus for antibodies to multiple
KT-associated proteins and to the loading control anti-Histone H4.
(B) BuGZ stabilizes Bub3 expression in interphase and mitotic cells. Western blot analysis of GSC-0131 and HeLa interphase or mitotic cell extracts for
anti-BuGZ, anti-Bub3, and loading control anti-Histone H4 antibodies. GSC-0131 cells were infected with shControl or shBuGZ virus and treated
with the proteasome inhibitor MG-132 for 18.5 hr. HeLa cells were not treated with MG-132. Interphase and mitotic cells were collected by shake-off for both
GSC-0131 and HeLa cells. *Mitotic extracts contain additional lower-molecular-weight species of BuGZ, which could represent a cleavage or degradation
product.
(C) Knockdown of BuGZ does not alter BUB3mRNA levels and vice versa. qRT-PCR was used to access BuGZ and BUB3 mRNA expression after shRNA viral
infection with shControl, shBuGZ, and shBUB3. **Student’s t test, p < 0.01, +SD.
(D) Expression of BuGZ in BuGZ-depleted GSCs rescues Bub3 expression, but BuGZ-GLEBS domain mutants (E358K E359K) do not. Western blot analysis of
GSC-0131 cell extracts for anti-turboGFP, anti-BuGZ, anti-Bub3, and loading control anti-Histone H4 antibodies. GSC-0131 cells were first infected with BuGZ
(legend continued on next page)
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BuGZ Is Required for Bub3-Bub1 FunctionTo understand the source of these attachment errors, we as-
sayed Bub1 kinase activity, which is implicated in mediating
proper chromosome alignment through localization and activa-
tion of ABK (Kawashima et al., 2007; Tsukahara et al., 2010;
Yamagishi et al., 2010). We measured Bub1 kinase activity in
cells by immunostaining its substrate, histone H2AT120. Consis-
tent with loss of Bub1 at KTs, pH2A levels were significantly
lower after BuGZ depletion (Figure 6A). Consistent with loss of
ABK activity at KTs after BuGZ depletion, we also observed sig-
nificant loss of phosphorylation of Hec1S44, a critical down-
stream KT substrate of ABK that is involved in the regulation
of KT-MT attachments (Figure 6A; DeLuca et al., 2011). Thus,
BuGZ affects chromosome alignment by ensuring Bub3-medi-
ated recruitment of Bub1, which in turn ensures appropriate
ABK-mediated phospho-regulation of KT-MT attachments.
However, unlike Bub1 and BubR1, BuGZ-depleted cells re-
tained a functional SAC response and elicited a significant
mitotic delay in response to MT poisons, albeit at diminished
levels (Figures 6B and S6). BuGZ- and Bub3-codepleted cells
did not sustain a checkpoint arrest under these same conditions,
which was similar to the behavior of cells depleted of Bub3 alone
(Figure 6C). These results suggest that BuGZ-depleted cells
have enough residual Bub1 and Bub3 to activate the SAC.
DISCUSSION
Here, we report that the human BuGZ/ZNF207 gene encodes
a GLEBS-domain-containing and KT-binding protein that is
required for Bub3 stability, Bub1 KT function, and chromosome
alignment. A model for BuGZ function is presented in Figure 6D.
We propose that BuGZ activity is required for Bub3 stability
during interphase and mitosis. BuGZ depletion, therefore, re-
sults in a reduction of Bub3 protein levels during interphase
and decreased binding to KTs during mitosis. As a conse-
quence, Bub3-dependent Bub1 recruitment to KTs is compro-
mised. This, in turn, compromises Bub1-dependent recruitment
of ABK, which causes lethal chromosome congression defects
in cancer cells. Importantly, viability defects and chromosome
alignment defects resulting from BuGZ depletion were recre-
ated in nonsensitive cells through oncogenic transformation.
This suggests that oncogenic stress can drive an added
requirement for BuGZ function in our GBM isolates and other
cancer lines.
We previously established that GSCs differentially require
BubR1’s GLEBS domain to suppress the lethal consequences
of altered KT function by promoting attachment of MTs to KTs
(Ding et al., 2013). Similar to the case with BuGZ, the BubR1-
GLEBS viability requirement can be reproduced in nonsensitive
cells through genetic transformation with RasV12. However,
the phenotypes associated with the BubR1-GLEBS-domain
requirement appear to be distinct from those observed for
BuGZ. For example, BubR1 knockdown results in severe defects
in KT-MT attachment in GBM isolates with short inter-KTDZF2 (shBuGZ_1 targets the second zinc fingermotif), shBuGZ-resistant (denoted
selection, these cells were virally transduced with shControl or shBuGZ.
(E) BuGZ localizes to KTs in prophase and prometaphase, but diminishes during m
DAPI, GFP, and KTs (anticentromere antibody [ACA]). Representative images are
See also Figure S3.
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alignment defects similar to those produced by Bub3 depletion
in all GSC isolates (Figure 5E). We postulate that GBM isolates
and transformed NSCs have an added requirement for BuGZ
due to oncogenic signaling that leads to changes in either KT
protein activity (e.g., through changes in stoichiometry) or feed-
back regulation of genes involved in chromosome congression
(e.g., ABK). Based on these studies, the RTK/Ras pathway is a
likely candidate for triggering a BuGZ requirement. The RTK/
Ras pathway is overactivated in many cancers, including GBM,
and there is evidence that the Ras downstream effectors Erk1/
2 can directly phosphorylate the C-terminal domain of CENPE,
a key KT protein, which is predicted to decrease its MT-binding
ability (Benanti and Galloway, 2004).
The functional dichotomy between BuGZ and BubR1 is also
observed in the SAC. BubR1’s essential function is to maintain
an intact mitotic checkpoint until all chromosomes are properly
aligned and KTs are under proper tension. We observed a signif-
icant mitotic delay in cancer cells following depletion of BuGZ
despite a significant loss of both Bub1 and Bub3 at the KTs (Fig-
ures 6B and S6). This mitotic delay is checkpoint dependent,
as codepletion of BuGZ and Bub3 prevented mitotic arrest (Fig-
ure 6C). Thus, it is likely that unattached KTs present in BuGZ-
depleted cells are able to generate a functional SAC signal. It
is known that Bub1must be depleted >95% to cause checkpoint
abrogation (Meraldi and Sorger, 2005). Therefore, the >40% of
Bub3 and Bub1 present in BuGZ-depleted cells is likely sufficient
for SAC activation. However, we cannot preclude the possibility
that BuGZ is also involved in SAC silencing, which would
contribute to the observed mitotic delay.
Our studies raise a key question: Is BuGZ essential in non-
transformed cells? Bub1, Bub3, and BubR1 are all essential for
mouse development, because null mutations of these genes
cause early embryo lethality (Kalitsis et al., 2000; Malureanu
et al., 2009; Perera et al., 2007; Wang et al., 2004). However,
the heterozygous state is permissive for normal development,
albeit with increases in mitotic abnormalities. Consistent with
being nonessential, BubR1’s GLEBS domain is not required for
mouse embryo fibroblast proliferation or KT-MT attachment
(Ding et al., 2013; Malureanu et al., 2009). Our knockdown
studies suggest that the hypomorphic BuGZ state is permissive
for viability of nontransformed cells, where Bub3 expression is
probably equivalent to that in Bub3 heterozygous cells. How-
ever, we do not know whether complete removal of BuGZ would
reduce Bub3 levels further, or whether BuGZ has other essential
functions not revealed by our studies (e.g., in its zinc finger
domains). It will also be interesting to see whether GLEBS
domains are essential for mammalian development, given that
our findings suggest that targeting GLEBS-domain interactions
with Bub3 might represent a precision therapy for GBM.
Our findings also raise a critical question regarding BuGZ’s
role in facilitating Bub3’s function: How does BuGZ regulate
Bub3’s stability? One possibility is that upon Bub3 binding,by *) full-length (FL)BuGZ, or shBuGZ-resistantBuGZ E358K E359K. Following
etaphase. HeLa cells were transfected with GFP-BuGZ fusions and imaged for
shown.
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Figure 4. BuGZ Colocalizes with Bub3 at KTs during Early Mitosis by Virtue of its GLEBS Domain and Reduces Bub3 Levels at KTs when
Inhibited
(A) BuGZ and Bub3 colocalization in HeLa cells transfected with GFP-BuGZ and mCherry-BUB3 expression constructs. BuGZ and Bub3 colocalize during
prophase and prometaphase. Representative images are shown.
(B) BuGZ localization in HeLa cells infected with GFP-BuGZ DZF1, DZF2, or BuGZ DGLEBS mutants. BuGZ DZF1, DZF2 localizes to the KTs, whereas BuGZ
DGLEBS does not. KTs are stained with ACA.
(C) BuGZ localization is Bub3 dependent. HeLa cells stably expressing BuGZ-mCherry were infected with shControl, shBuGZ, or shBUB3, selected, and stained
with ACA.
(legend continued on next page)
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BuGZ Is Required for Bub3-Bub1 FunctionBuGZ’s GLEBS domain masks posttranslational modifications
of Bub3, such as phosphorylation, ubiquitination, or sumoyla-
tion, which prevent its degradation. However, we were unable
to detect increases in Bub3 expression from BuGZ-depleted
cells treated with the proteasome inhibitor MG132 (Figure 3B)
or the sumoylation inhibitor ginkgolic acid (data not shown).
Another possibility is that BuGZ acts as a molecular chaperone
for Bub3 by converting an unfolded or partially folded Bub3
into its final compact and stable confirmation (Larsen et al.,
2007), which, for example, might prevent specific proteases
from recognizing and degrading unfolded Bub3. Overexpression
of BuGZ increases the steady-state levels of both ectopically
expressed and endogenous Bub3 (Figures 2F and 3D), suggest-
ing that BuGZ expression is rate limiting for Bub3 stability. Thus,
further experimentation is warranted to determine the nature of
the change in Bub3 turnover following BuGZ depletion.
Another question is, how does BuGZ-dependent Bub3 regula-
tion affect Bub1 and BubR1 function at KTs? Bub3 and its bind-
ing partners Bub1 and BubR1 exhibit interdependencies for KT
localization (Lara-Gonzalez et al., 2012; Santaguida and Musac-
chio, 2009). Our results suggest that BuGZ loss preferentially
depletes Bub1 recruitment to the KT, leaving BubR1 levels un-
changed (Figure 5A). This appears to contradict previous studies
that have established roles for Bub1 and Bub3 in recruiting
BubR1 to KTs (Klebig et al., 2009; Liu et al., 2006; Logarinho
et al., 2008; Perera et al., 2007; Primorac and Musacchio,
2013; Taylor et al., 1998). However, these studies produced
knockdowns of >90% of Bub1 or Bub3. Our studies produced
more modest changes in Bub3 levels after BuGZ knockdown
(Figure 4F) and only partial loss of recruitment of Bub1 to KTs
(Figure 5A). This suggests that BubR1 might outcompete Bub1
at KTs for residual Bub3 (e.g., BubR1 could have a higher affinity
for Bub3 than for Bub1). Alternatively, BuGZ could act as an
exchange factor in facilitating Bub3-Bub1 interactions.
Further, it was recently found that Bub3 KT recruitment
is driven by Mps1/TTK-dependent phosphorylation of KNL1’s
MELT motifs (Kiyomitsu et al., 2007; London et al., 2012; Pri-
morac andMusacchio, 2013; Yamagishi et al., 2012). Consistent
with this result, we found that BuGZ KT localization is KNL1
dependent (Figure 4D). Interestingly, Bub3 binding of phosphor-
ylated MELT motifs is 10-fold greater when Bub1 is present
(Primorac et al., 2013). Future work will be required to determine
whether BuGZ, Bub1, and BubR1 have similar effects on KNL1-
dependent Bub3 KT localization.
In summary, we find that BuGZ is a GLEBS-domain-contain-
ing and KT-binding protein that is required for Bub3 stability
and KT function. In transformed cells, BuGZ knockdown results
in defects in KT-MT attachments and chromosome congression.
For cancer biology, these results raise the possibility that inhibit-
ingGLEBS domain interactionswith Bub3might be a therapeutic
strategy for refractory cancers like GBM, which suffer from lethal
KT-MT instability brought about by oncogenic stress (Ding et al.,
2013). For evolutionary biology, these results suggest that BuGZ(D) BuGZ KT localization requires KNL1. HeLa cells stably expressing BuGZ-GFP
(E) BuGZ KT binding is regulated by KT-MT attachment. GFP-BuGZ stable HeLa
(F) Bub3 total and KT-associated protein decreases after BuGZ depletion. Norm
rescence (right) (n = 2; error bars represent cellular deviation [control] and exper
See also Figure S4.
290 Developmental Cell 28, 282–294, February 10, 2014 ª2014 Elsevfunction might have arisen in higher eukaryotes to facilitate Bub3
function and chromosome congression.
EXPERIMENTAL PROCEDURES
Western blotting, affinity purification, mass spectrometry, and immunoprecip-
itations were performed according to standard protocols. Refer to the Supple-
mental Experimental Procedures for details.
Cell Culture and Drug Treatment
GSC and NSC lines were grown in N2B27 neural basal media (StemCell
Technologies) supplemented with epidermal growth factor (EGF) and
fibroblast growth factor 2 (FGF-2; 20 ng/ml each; Peprotech) on laminin
(Sigma) coated polystyrene plates and passaged as described previously
(Ding et al., 2013; Hubert et al., 2013). Specifically, cells were detached
from their plates using Accutase (Millipore), centrifuged, and resuspended
with the appropriate media every 3–4 days. 293T and HeLa cells (ATCC)
were grown in 10% fetal bovine serum (FBS)/Dulbecco’s modified Eagle’s
medium (Invitrogen). Cells were incubated with 800 nM or 10 mM nocoda-
zole (Sigma) for 24 hr or 1 hr, respectively. Taxol (Sigma) was used at
10 mM for 24 hr, and MG132 (Tocris) was also used at a final concentration
of 10 mM. Live-cell imaging was performed in Leibovitz’s L-15 media
(Invitrogen) supplemented with 10% FBS, 7 mM HEPES pH 7.0, and
4.5 g/l glucose.
Growth Assays
For short-term single clone validation assays, cells were infectedwith lentivirus
containing a single shRNA to the respective gene. Following selection, cells
were harvested, counted (NucleoCounter; NBS), and plated in triplicate onto
96-well plates coated with laminin (Ding et al., 2013; Hubert et al., 2013). After
7 days under standard growth conditions with 0.5 mg/ml of puromycin to main-
tain selection and prevent outgrowth of residual uninfected cells, cell-prolifer-
ation rates were measured using Alamar blue reagent (Invitrogen) according to
themanufacturer’s instructions. For analysis, shRNA-containing sampleswere
normalized to their respective shControl samples.
Western Blotting
Western blots were carried out according to standard laboratory practices
(http://www.cshprotocols.org), except that cells were lysed in a modified
RIPA buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 2 mM MgCl2, 0.1% SDS,
2 mM dichlorodiphenyltrichloroethane, 0.4% deoxycholate, 0.4% Triton
X-100, 13 complete protease inhibitor cocktail [complete Mini EDTA-free;
Roche], and 1 U/ml benzonase nuclease [Novagen]) at room temperature for
15 min (Chen et al., 2012; Ding et al., 2013; Hubert et al., 2013). Additionally,
some cells were subjected to treatment with the protease inhibitor MG-132
(EMD Millipore) at 10 mM for 18.5 hr following the infection/selection process.
After a shake-off, cells in suspension (mitotic cells) were harvested. Cells that
remained attached to the culture plate were washed with PBS to remove the
remaining mitotic cells in culture and detached (interphase/asynchronous
cells). Attached cells were then washed with PBS and lysed using themodified
RIPA buffer.
Immunofluorescence
Cellsweregrownonsterileacid-washedcoverslips in35mmcell-culturedishes.
The cells were rinsed with PHEM (60 mM PIPES, 25 nM HEPES, 10 mM EGTA,
4mMMgSO4) and either immediately treated with 4%paraformaldehyde (PFA)
for 20 min at room temperature or (for phosphorylation-specific antibodies)
treated with lysis buffer (PHEM + 1.0% Triton X-100) for 5 min at 37C and
then PFA fixed for 20 min at room temperature. Fixed cells were washed and
thenblocked for 1 hr at room temperature in PHEM+ 10%boiled donkey serumwere transfected with siControl or siKNL1 and stained with ACA.
cells were treated as shown with nocodazole or taxol and imaged.
alized protein levels were determined by western blot (left) and immunofluo-
imental deviation [BuGZ siRNA]).
ier Inc.
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Figure 5. BuGZ Activity Is Required for Proper Chromosome Alignment
(A) Immunofluorescence analysis of BubR1 and Bub1 KT association. Representative images (left) and quantitative analysis (right) show that BuGZ depletion
does not alter BubR1 levels, but Bub1 localization is significantly reduced (Student’s t test p < 0.001). The total protein levels of both BubR1 and Bub1 are
unaltered (Figure 3; n = 2; error bars represent cellular deviation [control] and experimental deviation [BuGZ siRNA]).
(B) BuGZ depletion causes chromosome alignment defects in HeLa cells. After MG132 treatment, 35% of BuGZ-depleted cells align chromosomes, compared
with 85% of control cells (>800 cells counted/condition; +SD).
(C) BuGZ depletion causes chromosome alignment defects in transformed NSC-CB660 and GSC-0131 cells, but not in nontransformed NSC-CB660 cells. After
2 hr of MG132 treatment, 70% of BuGZ-depleted NSC-CB660 cells align chromosomes, compared with 45% of BuGZ-depleted transformed NSC-CB660 cells
(>395 cells counted/condition; +SD).
(D) In GSC-0131 cells, BuGZ and Bub3 codepletion causes chromosome alignment defects similar to those observed with BuGZ and Bub3 depletion alone. After
2 hr of MG132 treatment, 26% of BuGZ/Bub3-codepleted GSC-0131 cells align chromosomes, compared with 19% of BuGZ-depleted cells and 43% of
Bub3-depleted cells (>535 cells counted/condition; +SD).
(E) Ectopic expression of wild-type BuGZ, but not BuGZ GLEBS-domain mutants (E358K E359K), rescues chromosome alignment defects in GSCs
depleted for endogenous BuGZ. After 2 hr of MG132 treatment, 59% of BuGZ-depleted GSCs expressing shBuGZ-resistant (denoted by *) full-length
(legend continued on next page)
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Bub1 dependent 
H2A phosphorylation
Figure 6. BuGZ Activity Is Required for Localization and Activation of ABK, and the SAC
(A) Immunofluorescence analysis for kinase activity of Bub1 and Aurora B. Representative images (left) and quantitative analysis (right) show that BuGZ depletion
decreases phosphorylation of the Bub1 and Aurora B substrates H2A and Hec1, respectively. ***Student’s t test p < 0.001; n = 2; error bars represent cellular
deviation (control) and experimental deviation (BuGZ siRNA).
(B) BuGZ-depleted cells sustain amoderatemitotic arrest in MT poisons. Amajority of control (black) and attachment factor Hec1 (blue) depleted cells are mitotic
after 24 hr in taxol. Depleting the SAC proteins BubR1 (gray) and Bub1 (green) causes premature mitotic exit. BuGZ depletion (red) causes an intermediate
phenotype, suggesting that cells establish a SAC response but cannot maintain it (n = 2; >1,000 cells counted/condition; +SD).
(C) BuGZ and Bub3 codepleted cells (blue) do not sustain a checkpoint arrest. A majority of control depleted cells (black) are mitotic after 24 hr in taxol. Depleting
the SAC proteins BubR1 (gray) and Bub3 (green) causes a premature mitotic exit, whereas BuGZ depletion (red) causes an intermediate phenotype. Thus,
BuGZ-induced arrests require checkpoint signaling (n = 3; >1,000 cells counted/condition; +SD).
(D) Model of BuGZ function.
See also Figure S6.
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BuGZ Is Required for Bub3-Bub1 Function(BDS). Primary antibodies were diluted in PHEM + 5% BDS and incubated for
16 hr at 4C. See the Supplemental Experimental Proceduresfor further details.
Transformed NSCs
Normal CB660 NSCs were simultaneously infected with retrovirus containing
pBABE-hTERT + p53DD (Plasmid 11128; Addgene), pBABE-cyclinD1 +
CDK4R24C (Plasmid 11129; Addgene), and pBABE-c-mycT58A + HRasG12V
(Plasmid 11130; Addgene) for three consecutive rounds of infection (HubertBuGZ display aligned chromosomes, compared with 34% for the BuGZ
condition; +SD).
(F) BuGZ depletion delays mitotic timing. HeLa cells expressing H2B-GFP fusio
envelope breakdown until anaphase onset. The average mitotic timing for BuGZ
Whitney test, p < 0.001; n > 60 cells/condition; +SD.
See also Figure S5.
292 Developmental Cell 28, 282–294, February 10, 2014 ª2014 Elsevet al., 2013). After recovery, cells were selected with neomycin for Ras and
blasticidin for c-myc.
SSEA1+ Outgrowth Assays
Cells were infected with shControl and shBuGZ virus for 48 hr, followed by se-
lection with puromycin for 72 hr. The cells were detached from their respective
plate, counted with a NucleoCounter, and mixed with untreated cells. After
mixing, the cells were seeded to a six-well tissue-culture dish coated withallele containing mutations in the GLEBS domain (>445 cells counted/
n protein were imaged at 5 min intervals to determine the time from nuclear
-depleted cells was 120 min, compared with 60 min in control cells. ***Mann-
ier Inc.
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BuGZ Is Required for Bub3-Bub1 Functionlaminin for further growth. After 3 days in culture, the cells were harvested,
counted, seeded onto a 6-well tissue-culture dish coated with laminin for
further growth, or washed with cold PBS containing 0.5% BSA for flow
analysis. The cells were analyzed at days 0, 3, 7, 14, and 21. Data analysis
was performed using FlowJo (Three Star). See the Supplemental Experimental
Proceduresfor further details.
Limiting Dilution Assay
Cells were infected with shControl or shBuGZ virus for 48 hr, followed by
selection with puromycin for 72 hr (day 0). The cells were detached from their
respectiveplate, dissociated intosingle-cell suspensions,countedwithaNucle-
oCounter, and thenplatedonto non-tissue-culture-treated, non-laminin-coated
96-well platesat variousseedingdensities (0.125–256cells perwell, 10wells per
seedingdensity). Thecellswere incubatedat 37C for 3weeks and fedwith 103
EGFandFGF-2NSCexpansionmedia every 3–4days. At the timeof quantifica-
tion, each well was examined for the formation of tumor spheres.
Xenotransplantation
For xenotransplantation, 0827 GSCs were infected with pGIPZ shRNA virus
and selected for 3 days in puromycin (1 mg/ml). Cells were then harvested using
Accutase (Sigma), counted, resuspended in an appropriate volume of culture
media, mixed with 90%GIPZ plus 10% untreated cells (noninfected cells), and
kept on ice prior to immediate transplantation (Hubert et al., 2013). NOD-scid
IL2Rgammanull mice (#005557; The Jackson Laboratory) were sedated by
inhalation of isoflurane. A small-bore hole was made in the skull using a
hand drill with a Meisinger #009 steel burr bit (Hager and Meisinger). Then
13 105 cells were slowly injected by pipet into the right frontal cortex approx-
imately 2 mm rostral to bregma, 2 mm lateral, and 3 mm deep through a 0.2–
10 ml disposable sterile aerosol barrier tip (#02-707-30; Fisher Scientific). The
burr hole was closed using SURGIFOAM (Johnson & Johnson) and the skin
was rejoined using Tissumend II (Veterinary Product Laboratories). Seventeen
days after the initial transplantation, the mice were injected intravenously
through the tail with 100 ml of 10 mM chlorotoxin:indocyanine green (Blaze
Bioscience) 4 hr prior to sacrifice by carbon dioxide inhalation. The brain
and tumor were removed from the skull and imaged for GFP and indocyanine
green fluorescence using the Xenogen IVIS Spectrum imaging system (Caliper
Life Sciences). All mouse studies were conducted in accordance with proto-
cols approved by the Institutional Animal Care and Use Committee.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2013.12.014.
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